| Risk | High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 1.98% |
| NAV | ₹183.13 (25 Sep 2020) |
|---|---|
| Fund Started | 30 Sep 1994 |
| Fund Size | ₹3,854 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Britannia Industries Ltd. | FMCG | Equity | 8.3% |
| Colgate-Palmolive (India) Ltd. | FMCG | Equity | 7.8% |
| Nestle India Ltd. | FMCG | Equity | 6.0% |
| Maruti Suzuki India Ltd. | Automobile | Equity | 4.8% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 4.2% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 3.5% |
| PI Industries Ltd. | Chemicals | Equity | 3.5% |
| Procter & Gamble Hygiene & Health Care Ltd. | FMCG | Equity | 3.5% |
| Sanofi India Ltd. | Healthcare | Equity | 3.4% |
| Hindustan Unilever Ltd. | FMCG | Equity | 3.4% |
SBI Magnum Global Fund Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 30 Sep 1994. Rama Iyer Srinivasan is the Current Fund Manager of SBI Magnum Global Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹3,854 Cr and the Latest NAV as of 25 Sep 2020 is ₹183.13.
The SBI Magnum Global Fund Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 12 months.
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in diversified portfolio comprising primarily of MNC companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.